Anti-CLEC17A monoclonal antibody

Pre-made anti-CLEC17A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CLEC17A/CLEC17A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0556-Ab-1/ GM-Tg-hg-IP0556-Ab-2Anti-Human CLEC17A monoclonal antibodyHuman
GM-Tg-rg-IP0556-Ab-1/ GM-Tg-rg-IP0556-Ab-2Anti-Rat CLEC17A monoclonal antibodyRat
GM-Tg-mg-IP0556-Ab-1/ GM-Tg-mg-IP0556-Ab-2Anti-Mouse CLEC17A monoclonal antibodyMouse
GM-Tg-cynog-IP0556-Ab-1/ GM-Tg-cynog-IP0556-Ab-2Anti-Cynomolgus/ Rhesus macaque CLEC17A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0556-Ab-1/ GM-Tg-felg-IP0556-Ab-2Anti-Feline CLEC17A monoclonal antibodyFeline
GM-Tg-cang-IP0556-Ab-1/ GM-Tg-cang-IP0556-Ab-2Anti-Canine CLEC17A monoclonal antibodyCanine
GM-Tg-bovg-IP0556-Ab-1/ GM-Tg-bovg-IP0556-Ab-2Anti-Bovine CLEC17A monoclonal antibodyBovine
GM-Tg-equg-IP0556-Ab-1/ GM-Tg-equg-IP0556-Ab-2Anti-Equine CLEC17A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0556-Ab-1/ GM-Tg-hg-IP0556-Ab-2; GM-Tg-rg-IP0556-Ab-1/ GM-Tg-rg-IP0556-Ab-2;
GM-Tg-mg-IP0556-Ab-1/ GM-Tg-mg-IP0556-Ab-2; GM-Tg-cynog-IP0556-Ab-1/ GM-Tg-cynog-IP0556-Ab-2;
GM-Tg-felg-IP0556-Ab-1/ GM-Tg-felg-IP0556-Ab-2; GM-Tg-cang-IP0556-Ab-1/ GM-Tg-cang-IP0556-Ab-2;
GM-Tg-bovg-IP0556-Ab-1/ GM-Tg-bovg-IP0556-Ab-2; GM-Tg-equg-IP0556-Ab-1/ GM-Tg-equg-IP0556-Ab-2
Products NameAnti-CLEC17A monoclonal antibody
Formatmab
Target NameCLEC17A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CLEC17A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0556-Ag-1Recombinant multi-species CL17A/ CLEC17A protein


    Target information

    Target IDGM-IP0556
    Target NameCLEC17A
    Gene ID388512,106994645,610758,101098039,100299814,100064877
    Gene Symbol and SynonymsCLEC17A
    Uniprot AccessionQ6ZS10
    Uniprot Entry NameCL17A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000187912
    Target ClassificationN/A

    The target: CLEC17A, gene name: CLEC17A, also named as . Enables fucose binding activity; identical protein binding activity; and mannose binding activity. Located in cell surface. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.